PLAT and Stroke: Lastly, evaluating miR changes in age-related neurological conditions should be assessed in the context of the treatment regimens typically employed and known to induce neurobeneficial effects (i.e. tPA and stroke), as these considerations will be critical to understanding the cellular mechanisms of actions of current therapeutic treatments, and developing more specific interventions.